Ascentage Pharma Group Earnings Estimates, EPS & Revenue | NASDAQ:AAPG

Comments

Ascentage Pharma Group International Earnings Estimates

AAPGNASDAQ

Trade with Public

$24.22

-0.27-1.10%

At close: Mar 10, 5:00 PM EST

$23.70

-0.79-3.23%

Pre-Market: 7:00 AM EST

Earnings: FY 2025 Earnings in 13 days from now on Wed Mar 25th, after the market close

Overview NewsEarningsAnalyst Ratings Short Interest Stock Report

Ascentage Pharma Group Earnings Estimates, EPS & Revenue | NASDAQ:AAPG

Ascentage Pharma Group (AAPG) is scheduled to report FY earnings on March 25, 2026. Analysts estimate EPS of N/A and quarterly revenue of $83.00M.

Earnings Date

Aug 20

EPS

$-0.240

Quarterly Revenue

$32.62M

Annual Revenue
(as of Jun 30)

$390.60M

Ascentage Pharma Group Earnings History

Analyze the earnings history of Ascentage Pharma Group using advanced sorting and filters.

Ascentage Pharma Group (AAPG) Earnings Per Share

The chart below shows Ascentage Pharma Group's reported EPS compared to analyst estimates over recent quarters.

Ascentage Pharma Group (AAPG) Revenue

The chart below shows Ascentage Pharma Group's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Ascentage Pharma Group (NASDAQ:AAPG) reporting earnings?

Ascentage Pharma Group (AAPG) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on August 20, 2025 for H1.

What were the latest earnings per share (EPS) for Ascentage Pharma Group (NASDAQ:AAPG)?

The Actual EPS was $-0.24, which missed the estimate of $0.00.

What were Ascentage Pharma Group’s (NASDAQ:AAPG) revenues?

The Actual Revenue was $32.62M, which beat the estimate of $0.00.

People Also Watch

Ascentage Pharma Group Earnings Estimates, EPS & Revenue | NASDAQ:AAPG

Ascentage Pharma Group (AAPG) is scheduled to report FY earnings on March 25, 2026. Analysts estimate EPS of N/A and quarterly revenue of $83.00M.

Earnings Date

Aug 20

EPS

$-0.240

Quarterly Revenue

$32.62M

Annual Revenue
(as of Jun 30)

$390.60M